Potential public health impact of a Neisseria meningitidis A, B, C, W, and Y pentavalent vaccine in the United States-Reference-Cited by-同舟云学术

Potential public health impact of a Neisseria meningitidis A, B, C, W, and Y pentavalent vaccine in the United States

Published:2021-02-22 Issue: Volume: Page:1-8
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Huang Liping¹^ORCID,Snedecor Sonya J.²^ORCID,Balmer Paul³^ORCID,Srivastava Amit³^ORCID

Affiliation:

1. Patient Health and Impact, Pfizer Inc, Collegeville, PA, USA

2. Health Economics, Pharmerit – an OPEN Health Company, Bethesda, MD, USA

3. Vaccines Medical Development, Scientific & Clinical Affairs, Pfizer Inc, Collegeville, PA, USA

Funder

Pfizer Inc

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2021.1876478

Reference63 articles.

1. The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines

2. Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements

3. Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report, 2018 [Internet]. 2019 [cited 2020 Jul 2]. Available from: https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2018.pdf

4. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: A systematic review and meta-analysis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meningococcal Vaccination of Adolescents in the United States: Past Successes and Future Considerations;Journal of Adolescent Health;2024-06

2. Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB;Journal of Infection;2022-11

3. Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review;Infectious Diseases and Therapy;2022-03-31